Related references
Note: Only part of the references are listed.Substrate-Guided Design of a Potent and Selective Kallikrein-Related Peptidase Inhibitor for Kallikrein 4
Joakim E. Swedberg et al.
CHEMISTRY & BIOLOGY (2009)
Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective
Nicolas Guex et al.
ELECTROPHORESIS (2009)
Lessons Learned in Antifibrinolytic Therapy: The BART Trial
John M. Murkin
SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA (2009)
Potent and selective peptidyl boronic acid inhibitors of the serine protease Prostate-Specific Antigen
Aaron M. LeBeau et al.
CHEMISTRY & BIOLOGY (2008)
D-SAP:: A new, noncytotoxic, and fully protease resistant cell-penetrating peptide
Silvia Pujals et al.
CHEMMEDCHEM (2008)
Discovering and improving novel peptide therapeutics
Duncan Patrick McGregor
CURRENT OPINION IN PHARMACOLOGY (2008)
Distribution and Evolution of Circular Miniproteins in Flowering Plants
Christian W. Gruber et al.
PLANT CELL (2008)
Novel small molecule inhibitors for prostate-specific antigen
Hannu Koistinen et al.
PROSTATE (2008)
Substrate specificity of human kallikreins 1 and 6 determined by phage display
Hai-Xin Li et al.
PROTEIN SCIENCE (2008)
Genetic features of circular bacteriocins produced by Gram-positive bacteria
Mercedes Maqueda et al.
FEMS MICROBIOLOGY REVIEWS (2008)
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control I desquamation through a pH-dependent interaction
Celine Deraison et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea
Kenshi Yamasaki et al.
NATURE MEDICINE (2007)
Activity and stability of human kalikrein-2-specific linear and cyclic peptide inhibitors
Miikka Pakkala et al.
JOURNAL OF PEPTIDE SCIENCE (2007)
Delivery methods for peptide and protein toxins in insect control
Paul A. Whetstone et al.
TOXICON (2007)
What is hidden behind peptide bond restriction and α-carbon asymmetry of conserved antigens?: Peptide bond isosters and chirally transformed pseudopeptides as novel elements for synthetic vaccines and therapeutic agents against malaria
JM Lozano et al.
CURRENT ORGANIC CHEMISTRY (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides
Y Hamada et al.
CHEMICAL REVIEWS (2005)
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis
B Giusti et al.
ARTHRITIS AND RHEUMATISM (2005)
Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1
MLJ Korsinczky et al.
BIOCHEMISTRY (2005)
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries
M Matsumura et al.
PROSTATE (2005)
Role of imbalance between neutrophil elastase and α1-antitrypsin in cancer development and progression
ZF Sun et al.
LANCET ONCOLOGY (2004)
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies
A Iwata et al.
HUMAN MOLECULAR GENETICS (2003)
Engineering of a macromolecular scaffold to develop specific protease inhibitors
AA Stoop et al.
NATURE BIOTECHNOLOGY (2003)
Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease
A Stadnicki et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Human and mouse proteases:: A comparative genomic approach
XS Puente et al.
NATURE REVIEWS GENETICS (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
DX-88 and HAE: a developmental perspective
A Williams et al.
TRANSFUSION AND APHERESIS SCIENCE (2003)
α1-proteinase inhibitor mutants with specificity for plasma kallikrein and Cls but not Cl
T Sulikowski et al.
PROTEIN SCIENCE (2002)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Activity of a newly identified serine protease in CNS demyelination
IA Scarisbrick et al.
BRAIN (2002)
Characterization of hK4 (prostase), a prostate-specific serine protease: Activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase
TK Takayama et al.
BIOCHEMISTRY (2001)
The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation
H Potter et al.
NEUROBIOLOGY OF AGING (2001)
Expression of the kallikrein gene family in normal and Alzheimer's disease brain
C Shimizu-Okabe et al.
NEUROREPORT (2001)
Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR
TK Takayama et al.
BIOCHEMISTRY (2001)
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue
A Magklara et al.
UROLOGY (2000)
Share Paper
